The hemiplegic migraine-associated Y1245C mutation in CACNA1A results in a gain of channel function due to its effect on the voltage sensor and G-protein-mediated inhibition - PubMed (original) (raw)

. 2009 Jul;458(3):489-502.

doi: 10.1007/s00424-009-0637-3. Epub 2009 Feb 3.

Affiliations

The hemiplegic migraine-associated Y1245C mutation in CACNA1A results in a gain of channel function due to its effect on the voltage sensor and G-protein-mediated inhibition

Selma A Serra et al. Pflugers Arch. 2009 Jul.

Abstract

Mutations in the gene encoding the pore-forming alpha(1A) subunit of P/Q Ca(2+) channels (CACNA1A) are linked to familial hemiplegic migraine. CACNA1A Y1245C is the first missense mutation described in a subject affected with childhood periodic syndromes that evolved into hemiplegic migraine. Y1245C is also the first amino acid change described in any S1 segment of CACNA1A in a hemiplegic migraine background. We found that Y1245C induced a 9-mV left shift in the current-voltage activation curve, accelerated activation kinetics, and slowed deactivation kinetics within a wide range of voltage depolarizations. Y1245C also left-shifted the voltage-dependent steady-state inactivation with a significant increase in steepness, suggesting a direct effect on the P/Q channel voltage sensor. Moreover, Y1245C reduced Gbetagamma subunits-dependent channel inhibition probably by favoring Gbetagamma dissociation from the channel; an effect also observed using action-potential-like waveforms of different durations. The formation of a new disulfide bridge between cysteines may contribute to the Y1245C effects on activation and Gbetagamma inhibition of the channel, as they were significantly reversed by the sulphydryl-reducing agent dithiothreitol. Together, our data suggest that Y1245C alters the structure of the alpha(1A) voltage sensor producing an overall gain of channel function that may explain the observed clinical phenotypes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Invest. 2004 Apr;113(7):1032-9 - PubMed
    1. Annu Rev Cell Dev Biol. 2006;22:23-52 - PubMed
    1. J Neurosci. 1997 Aug 1;17(15):5772-81 - PubMed
    1. Pflugers Arch. 2008 Nov;457(2):315-26 - PubMed
    1. J Biol Chem. 2004 Dec 10;279(50):51844-50 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources